Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 | P01008 | 4/20 | 0.44 |
| ▸ | F10 | P00742 | 6/20 | 0.42 |
| ▸ | FGF1 | P05230 | 1/20 | 0.36 |
| ▸ | FGF2 | P09038 | 1/20 | 0.36 |
| ▸ | BDNF | P23560 | 3/20 | 0.35 |
| ▸ | PTN | P21246 | 2/20 | 0.35 |
| ▸ | MDK | P21741 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 2/20 | 0.34 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.30 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.30 |
| ▸ | CCL2 | P13500 | 1/20 | 0.30 |
| ▸ | CCL5 | P13501 | 1/20 | 0.30 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13008687 | 0.94 | SERPINC1 (0.48) | SERPINC1F10FGF1FGF2BDNF | |
| SCHEMBL13008574 | 0.91 | SERPINC1 (0.46) | SERPINC1F10FGF1FGF2BDNF | |
| SCHEMBL13008683 | 0.91 | SERPINC1 (0.46) | SERPINC1F10FGF1FGF2BDNF | |
| SCHEMBL12920566 | 0.73 | SERPINC1 (0.51) | SERPINC1F10FGF1FGF2 | |
| SCHEMBL13039102 | 0.72 | SERPINC1 (0.57) | SERPINC1F10FGF1FGF2BDNF | |
| SCHEMBL14363911 | 0.72 | SERPINC1 (0.57) | SERPINC1F10FGF1FGF2BDNF | |
| SCHEMBL13431400 | 0.72 | MDK (0.55) | SERPINC1F10FGF2BDNFPTN | |
| SCHEMBL12458587 | 0.72 | SERPINC1 (0.75) | SERPINC1F10FGF1FGF2F2 | |
| SCHEMBL13765947 | 0.71 | F10 (0.51) | SERPINC1F10BDNFPTNMDK | |
| SCHEMBL12606391 | 0.71 | SERPINC1 (0.58) | SERPINC1F10FGF1FGF2BDNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100317846-A1 | Production Of L-Iduronate Containing Polysaccharides | THE UNIVERSITY OF MANCHESTER (GB) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317846-A1 | Production Of L-Iduronate Containing Polysaccharides | IDUA, IDO1, IDO2 | SERPINC1 1729/4885F10 122/4885FGF1 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.